Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CNY 99.76 million compared to CNY 115.35 million a year ago. Net loss was CNY 8.38 million compared to net income of CNY 1.01 million a year ago. Basic loss per share from continuing operations was CNY 0.00443 compared to basic earnings per share from continuing operations of CNY 0.00053 a year ago.
For the nine months, sales was CNY 304.97 million compared to CNY 357.14 million a year ago. Net loss was CNY 21.63 million compared to net income of CNY 1.82 million a year ago. Basic loss per share from continuing operations was CNY 0.01142 compared to basic earnings per share from continuing operations of CNY 0.00096 a year ago.